On October 30, HRSA announced that it had selected eight drug manufacturers to participate in its 340B Rebate Model Pilot Program, spanning 10 drugs representing a range of widely used therapies. These include:
Continue Reading Preparing for HRSA’s 340B Rebate Model Pilot Program and the Beacon Platform
